API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
33
PharmaCompass offers a list of Flavoxate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flavoxate manufacturer or Flavoxate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flavoxate manufacturer or Flavoxate supplier.
PharmaCompass also assists you with knowing the Flavoxate API Price utilized in the formulation of products. Flavoxate API Price is not always fixed or binding as the Flavoxate Price is obtained through a variety of data sources. The Flavoxate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flavoxate HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flavoxate HCl, including repackagers and relabelers. The FDA regulates Flavoxate HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flavoxate HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flavoxate HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flavoxate HCl supplier is an individual or a company that provides Flavoxate HCl active pharmaceutical ingredient (API) or Flavoxate HCl finished formulations upon request. The Flavoxate HCl suppliers may include Flavoxate HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Flavoxate HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flavoxate HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Flavoxate HCl active pharmaceutical ingredient (API) in detail. Different forms of Flavoxate HCl DMFs exist exist since differing nations have different regulations, such as Flavoxate HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Flavoxate HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Flavoxate HCl USDMF includes data on Flavoxate HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Flavoxate HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Flavoxate HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Flavoxate HCl Drug Master File in Japan (Flavoxate HCl JDMF) empowers Flavoxate HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Flavoxate HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Flavoxate HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Flavoxate HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flavoxate HCl Drug Master File in Korea (Flavoxate HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flavoxate HCl. The MFDS reviews the Flavoxate HCl KDMF as part of the drug registration process and uses the information provided in the Flavoxate HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flavoxate HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flavoxate HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flavoxate HCl suppliers with KDMF on PharmaCompass.
A Flavoxate HCl written confirmation (Flavoxate HCl WC) is an official document issued by a regulatory agency to a Flavoxate HCl manufacturer, verifying that the manufacturing facility of a Flavoxate HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flavoxate HCl APIs or Flavoxate HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Flavoxate HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Flavoxate HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flavoxate HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Flavoxate HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Flavoxate HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Flavoxate HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flavoxate HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Flavoxate HCl suppliers with NDC on PharmaCompass.
Flavoxate HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flavoxate HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flavoxate HCl GMP manufacturer or Flavoxate HCl GMP API supplier for your needs.
A Flavoxate HCl CoA (Certificate of Analysis) is a formal document that attests to Flavoxate HCl's compliance with Flavoxate HCl specifications and serves as a tool for batch-level quality control.
Flavoxate HCl CoA mostly includes findings from lab analyses of a specific batch. For each Flavoxate HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flavoxate HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Flavoxate HCl EP), Flavoxate HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flavoxate HCl USP).